Amanda N. Fader, MD
Dr. Fader is an associate professor in the Johns Hopkins Medicine Department of Gynecology and Obstetrics. She is both the director of the Kelly Gynecologic Oncology Service and the director of the Center for Rare Gynecologic Cancers at The Johns Hopkins Hospital. She also directs the F.J. Montz Fellowship Program in Gynecologic Oncology.
She has extensive training and expertise in radical oncology surgery, advanced laparoscopy and robotics, and is an internationally recognized surgeon who is invited often to teach surgical techniques to others worldwide. She has lectured or performed surgery in more than 20 countries, and she has co-authored more than 100 publications in peer-reviewed medical journals. She is recognized as a leading expert in minimally invasive surgical innovations and rare gynecologic tumors, including high-risk uterine and ovarian cancers. She has a special interest in uterine serous carcinoma, low-grade serous carcinoma of the ovary, and uterine sarcomas.
Dr. Fader received her undergraduate degree with the highest distinction in music (violin performance) and premedicine from the University of Virginia. She earned her medical degree from the Virginia Commonwealth University School of Medicine in Richmond and completed her residency in obstetrics and gynecology at the Magee-Womens Hospital of UPMC in Pittsburgh. Dr. Fader then underwent gynecologic oncology fellowship training at Cleveland Clinic.
Dr. Fader serves on the editorial board of several journals, including Gynecologic Oncology and the Journal of Minimally Invasive Gynecology. She was selected to serve on several national committees, including the National Comprehensive Cancer Network’s Endometrial, Cervical and Vulvar Committee, and the Rare Tumor Committee of the NRG/Gynecologic Oncology Group. She also holds several leadership roles, including as the current president of the Mid-Atlantic Gynecologic Oncology Society and the outgoing chair of the Gynecologic Oncology Committee of the American Association of Gynecologic Laparoscopists. In 2015, she was selected as a national board examiner in gynecologic oncology for the American Board of Obstetrics and Gynecology.
Her research centers on minimally invasive surgical innovations in gynecologic oncology, immunotherapy and clinical trials, rare uterine and ovarian tumors, and quality and patient safety in gynecologic surgery. She has been the recipient of several research grants and awards for her research, including the Best Paper in Minimally Invasive Gynecologic Oncology Surgery at the American Association of Gynecologic Laparoscopists’ annual meeting and a National Cancer Institute Cervical SPORE Vaccine Project grant.
Dr. Fader is consistently recognized for clinical excellence on lists such as Baltimore magazine’s Top Docs and Castle Connolly’sTop Doctors, and is a recipient of the Top 10 Docs, Compassionate Doctors, and Patient Choice Awards from Vitals.com. She has particular expertise with the surgical and medical management of uterine (endometrial), ovarian, cervical, and vulvar cancers, as well as the treatment of women who are at high risk for developing a gynecologic malignancy. She has a special interest in caring for patients throughout the entire spectrum of their lives: from preventive oncology — minimizing key risk factors that can lead to gynecologic cancers — to survivorship initiatives addressing all aspects of recovery, including emotional well-being, sexual health, and clinical follow-up.